Edited by Yuriy Orlov and Ancha Baranova.
Citation: BMC Medical Genomics 2019 12(Suppl 2):36
Volume 12 Supplement 2
Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. YO is co-author of one of the articles and review of the article was handled entirely by AB. No other competing interests were declared.
Novosibirsk, Russia20-25 August 2018
Edited by Yuriy Orlov and Ancha Baranova.
Citation: BMC Medical Genomics 2019 12(Suppl 2):36
Approximately 5–20% of chronic myeloid leukemia (CML) patients demonstrate primary resistance or intolerance to imatinib. None of the existing predictive scores gives a good prognosis of TKI efficacy. Gene pol...
Citation: BMC Medical Genomics 2019 12(Suppl 2):37
Anlotinib has been demonstrated its anti-tumor efficacy on non-small cell lung cancer (NSCLC) in clinical trials at 3rd line. However, anlotinib resistance occurs during its administration, and the underlying ...
Citation: BMC Medical Genomics 2019 12(Suppl 2):38
Carotid body tumor (CBT) is a rare neoplasm arising from paraganglion located near the bifurcation of the carotid artery. There is great intra-tumor heterogeneity, and CBT development could be associated with ...
Citation: BMC Medical Genomics 2019 12(Suppl 2):39
The knowledge about specific mechanisms generating TP53 dysfunction in diffuse large B-cell lymphoma is limited. The aim of the current study was to comprehensively explore TP53 gene variability resulting from so...
Citation: BMC Medical Genomics 2019 12(Suppl 2):35
Inflammatory response plays a key role in the development of insulin resistance (IR) in obesity. Oxidative stress triggers the replication of the mitochondrial genome and division of the organelle. The purpose...
Citation: BMC Medical Genomics 2019 12(Suppl 2):40
Mitochondria play a central role in the regulation of energy metabolism, and the biogenesis of mitochondria is enhanced by the action of nitric oxide (NO), which is the key signaling molecule in the regulation...
Citation: BMC Medical Genomics 2019 12(Suppl 2):41
Thousands of long non-coding RNA (lncRNA) genes are annotated in the human genome. Recent studies showed the key role of lncRNAs in a variety of fundamental cellular processes. Dysregulation of lncRNAs can dri...
Citation: BMC Medical Genomics 2019 12(Suppl 2):42
Facial-scapular-humeral myodystrophy Landouzy-Dejerine (FSHD) is an autosomal dominant disease, the basis of its pathogenesis is ectopic expression of the transcription factor DUX4 in skeletal muscle. There ar...
Citation: BMC Medical Genomics 2019 12(Suppl 2):43
Cytotoxic activity of T- and NK-cells can be efficiently retargeted against cancer cells using chimeric antigen receptors (CARs) and rTCRs. In the context of solid cancers, use of armored CAR T- and NK cells s...
Citation: BMC Medical Genomics 2019 12(Suppl 2):44
The conditions of space flight have a significant effect on the physiological processes in the human body, yet the molecular mechanisms driving physiological changes remain unknown.
Citation: BMC Medical Genomics 2019 12(Suppl 2):45
Fat mass and obesity-associated (FTO) gene has been under close investigation since the discovery of its high impact on the obesity status in 2007 by a range of publications. Recent report on its implication in a...
Citation: BMC Medical Genomics 2019 12(Suppl 2):46
Currently, more than 150 million people worldwide suffer from lymphedema. It is a chronic progressive disease characterized by high-protein edema of various parts of the body due to defects in lymphatic draina...
Citation: BMC Medical Genomics 2019 12(Suppl 2):47
Age-related macular degeneration (AMD) is a major cause of blindness in developed countries, and the molecular pathogenesis of AMD is poorly understood. A large body of evidence has corroborated the key role o...
Citation: BMC Medical Genomics 2019 12(Suppl 2):48
Speed
91 days to first decision for reviewed manuscripts only
59 days to first decision for all manuscripts
161 days from submission to acceptance
22 days from acceptance to publication
Citation Impact
3.063 - 2-year Impact Factor
3.476 - 5-year Impact Factor
0.786 - Source Normalized Impact per Paper (SNIP)
1.113 - SCImago Journal Rank (SJR)
Usage
689,294 Downloads
595 Altmetric Mentions
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.